APRE financials
Aprea Therapeutics (APRE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
APRE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$13.23M | -$12.60M | -1.93 |
| 2024 | – | – | -$14.32M | -$12.96M | -2.35 |
| 2023 | – | – | -$15.47M | -$14.29M | -3.95 |
| 2022 | – | – | -$113.39M | -$112.66M | -67.99 |
| 2021 | – | – | -$37.45M | -$37.13M | -34.88 |
| 2020 | – | – | – | -$53.48M | -50.61 |